Clinical Trial Update: Very Early Surfactant and NCPAP for Premature Infants With RDS [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating very early surfactant administration with nasal CPAP in premature infants with respiratory distress syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Pneumothorax
• Pulmonary Interstitial Emphysema
• Respiratory Distress Syndrome

Drugs mentioned

• Exogenous Surfactant (surfactant)

Snippet

Sponsor: Colombian Neonatal Research Network | Conditions: Respiratory Distress Syndrome, Pneumothorax/Pulmonary Intersticial Emphysema | Phase 3 | Status: COMPLETED